Tranexamic acid is a synthetic drug that slows bleeding by helping blood clots stay intact. It works by blocking the body’s natural clot-dissolving process, making it useful for everything from heavy periods to life-threatening trauma. First developed in Japan in the early 1960s, it has since become one of the World Health Organization’s essential medicines and is now also widely used in skincare to treat dark spots and uneven skin tone.
How Tranexamic Acid Works
When you get a cut or injury, your body forms a blood clot to stop the bleeding. At the same time, your body also starts breaking that clot down through a process called fibrinolysis. This is normal and prevents clots from growing too large, but in some situations the clot-dissolving process works too aggressively and causes excessive bleeding.
Tranexamic acid is a synthetic version of lysine, an amino acid your body uses naturally. It attaches to the same binding sites on plasminogen, the protein responsible for dissolving clots. By occupying those sites, it prevents plasminogen from latching onto the clot and breaking it apart. The drug also directly blocks an enzyme called urokinase plasminogen activator, which is one of the key triggers that kicks off clot breakdown in the first place. The net effect: clots hold together longer, and bleeding slows or stops.
Common Medical Uses
The most familiar use for many people is treating heavy menstrual bleeding. Taken as a tablet during your period, tranexamic acid can significantly reduce blood loss without affecting your cycle length or hormonal balance. It’s a non-hormonal option, which makes it appealing for people who can’t or prefer not to use hormonal birth control for period management.
Beyond periods, the drug is used during and after surgeries where blood loss is a concern, including joint replacements, heart surgery, and dental procedures. It’s also prescribed for people with bleeding disorders and for nosebleeds that don’t respond to simpler measures. The WHO added tranexamic acid to its Model List of Essential Medicines in 2011 for general hemorrhage and expanded the listing in 2019 to include postpartum hemorrhage, the dangerous heavy bleeding that can follow childbirth.
Tranexamic Acid in Trauma and Emergency Care
One of the most significant findings about tranexamic acid came from the CRASH-2 trial, a landmark study of over 20,000 trauma patients across 40 countries. Patients who received the drug within hours of a serious injury had a 9% lower risk of dying from any cause compared to those who received a placebo. Deaths specifically from bleeding dropped by 15%. The key finding was that timing matters enormously. Treatment given within the first hour after injury produced the strongest benefit, and the drug was administered within an 8-hour window in the trial.
These results changed emergency protocols worldwide. Tranexamic acid is now a standard part of trauma care in many countries, carried by paramedics and stocked in emergency departments. It’s given intravenously as a loading dose followed by a slower infusion over several hours.
Treating Melasma and Dark Spots
Tranexamic acid has gained significant popularity in dermatology, particularly for melasma, the patchy brown or gray-brown discoloration that commonly appears on the face. Its mechanism here is different from its blood-clotting role. UV light triggers an enzyme called plasmin in skin cells, which in turn stimulates the cells that produce melanin (the pigment responsible for skin color). Tranexamic acid blocks that plasmin activity, reducing the chemical signals that tell your skin to overproduce pigment.
The results can be impressive. In a study of 561 patients taking 250 mg twice daily by mouth, nearly 90% showed visible improvement, with initial results appearing at a median of two months. A smaller study of 74 women found a 95.9% improvement rate after six months of oral use at the same dose. One important caveat: melasma recurred in about 27% of patients roughly seven months after stopping the oral form.
Topical tranexamic acid is also available, typically in concentrations of 2% to 10%, and is now a common ingredient in over-the-counter serums and creams. Topical formulations are gentler and carry fewer systemic risks, but they also produce more modest results. One comparison study found that oral tranexamic acid reduced melasma severity scores by 25%, while topical tranexamic acid achieved only a 5% reduction over 8 weeks. Combining topical tranexamic acid with microneedling appears to boost its effectiveness by helping it penetrate deeper into the skin.
Available Forms
Tranexamic acid comes in three main forms. Oral tablets are the most common for heavy periods and melasma. Intravenous formulations are used in hospitals for trauma, surgery, and postpartum hemorrhage. Topical versions, including creams, serums, and solutions, are used for skin pigmentation and are available both by prescription and over the counter in lower concentrations.
Side Effects
Oral tranexamic acid is generally well tolerated. The most commonly reported side effects are gastrointestinal: nausea, diarrhea, and abdominal discomfort. Some people experience headaches or muscle pain. These tend to be mild and often resolve as the body adjusts. Topical formulations rarely cause systemic side effects, though some users report mild skin irritation.
The more serious concern is the theoretical risk of blood clots, which follows logically from how the drug works. In practice, large studies like CRASH-2 have not found a significant increase in clot-related events like deep vein thrombosis or pulmonary embolism in most patient populations, but the risk is real for certain groups.
Who Should Avoid It
Tranexamic acid is not appropriate for everyone. It’s contraindicated in people with:
- Active blood clots or a history of venous or arterial clots (deep vein thrombosis, pulmonary embolism, stroke)
- Bleeding in the brain, including subarachnoid hemorrhage
- Defective color vision, because the drug can cause visual changes that would be difficult to detect
People taking combined hormonal contraceptives (the pill, patch, or ring) are typically advised to avoid oral tranexamic acid because both increase clotting risk. The same caution applies to certain clotting factor concentrates used to treat hemophilia. If you have a known bleeding disorder or a history of clots, the decision to use tranexamic acid requires careful weighing of risks and benefits on a case-by-case basis.